Translational Research Track

28th November – 08:30 – 09:45 – Session I
Education Track

Understanding the Diseases

Personalised medicine allows us to go beyond the treatment of the symptoms of diseases to understand their causes. This knowledge can offer new insights on how to manage the diseases and allows potential therapeutic targets for the development or repurposing of new therapies. This can be done by going back from gene identification to biomedical research.

The session will set out latest developments in the area and give a multi-stakeholder perspective on how this can be integrated into healthcare systems through the following themes:

  • Rare Diseases Model and Mechanism Network
  • Drug repurposing efforts

Chair

Etienne Richer

Etienne Richer

CIHR Institute of Genetics Associate Director

Panel

Rare Diseases Model and Mechanism Network

 Phil Hieter

Phil Hieter

Professor, Department of Medical Genetics Department of Biochemistry and Molecular Biology

Personalized risk stratification for prevention and early detection of breast cancer: Integration and Implementation

Jacques Simard

Jacques Simard

Canada Research Chair in Oncogenetics, Vice-Dean of Research and Graduate Studies, Full Professor, Faculty of Medicine, Université Laval

Giovanni Apolone

Giovanni Apolone

Scientific Director, Fondazione IRCCS Istituto Nazionale dei Tumori (INT) Milano